Immediate Impact
7 by Nobel laureates 13 from Science/Nature 66 standout
Citing Papers
The multifaceted role of autophagy in cancer
2022 Standout
Targeting the HIF2–VEGF axis in renal cell carcinoma
2020 StandoutNobel
Works of M. E. Scheulen being referenced
A randomised, double-blind, placebo-controlled trial of trametinib, an oral MEK inhibitor, in combination with gemcitabine for patients with untreated metastatic adenocarcinoma of the pancreas
2014
Phase I Clinical and Pharmacokinetic Study of the Novel Raf Kinase and Vascular Endothelial Growth Factor Receptor Inhibitor BAY 43-9006 in Patients With Advanced Refractory Solid Tumors
2004 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| M. E. Scheulen | 2572 | 2258 | 1146 | 178 | 5.5k | |
| Alexander Laird | 1650 | 2646 | 1197 | 95 | 4.8k | |
| Ferry A.L.M. Eskens | 2813 | 2570 | 1446 | 159 | 6.2k | |
| Annette K. Larsen | 2577 | 3610 | 800 | 161 | 6.8k | |
| Youcef M. Rustum | 3668 | 3480 | 1285 | 243 | 8.1k | |
| K. Mross | 3006 | 2069 | 1013 | 144 | 5.1k | |
| Scot C. Remick | 2706 | 1531 | 1009 | 155 | 6.0k | |
| Robert Justice | 2481 | 2757 | 1657 | 61 | 6.3k | |
| Jean‐Pierre Armand | 3673 | 2592 | 2015 | 161 | 6.8k | |
| Michelle A. Rudek | 2487 | 3763 | 1011 | 236 | 7.0k | |
| John G. Kuhn | 3365 | 3733 | 1773 | 188 | 8.6k |
All Works
Loading papers...